Review suggests vit D delays diabetes onset

19 January 2009

A recent review article published by researchers from the USA's Loyola University Chicago Marcella Niehoff School of Nursing concluded that  adequate intake of vitamin D may prevent or delay the onset of diabetes  and reduce complications for those who have already been diagnosed.

One study examined for this review article evaluated 3,000 people with  type 1 diabetes and found a decreased risk among those who took vitamin  D supplements. Observational studies of people with type 2 diabetes  also revealed that supplementation may prevent this disease.

According to the findings, which appeared in the January issue of  Diabetes Educator, many of the 23 million Americans with diabetes have  low vitamin D levels. Evidence suggests that vitamin D plays an integral  role in insulin sensitivity and secretion. A deficiency results in part  from poor nutrition, which is one of the most challenging issues for  people with diabetes. Another culprit is reduced exposure to sunlight,  which is common during cold weather months when days are shorter and  more time is spent indoors.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Company Spotlight